Skip to main content

Table 5 Mean and standard deviation (SD) costs, mean and SD quality-adjusted life years (QALYs), mean differences and incremental cost-effectiveness ratios during the trial follow-up period for intervention vs control groups (secondary analyses)

From: Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial

  Intervention mean (SD) Control mean (SD) Mean difference (95% CI) per patient P value
Intervention (A)           
Hospital utilization (B)           
Medical benefits (C)           
Pharmaceuticals (D)           
Patient costs (E)           
Total cost health system (A + B + C + D)       (1)     
Total cost societal (A + B + C + D + E)       (2)     
QALYs       (3)  
Incremental cost effectiveness ratio (ICER)        
 Health system perspective       (1)/(3)  
 Societal perspective       (2)/(3)  
  1. CI confidence interval